SSY Group wins China approval for antibiotic drug

SSY Group Limited announced that its antibiotic drug Morinidazole has received registration approval from China's National Medical Products Administration.

The approval allows Morinidazole to be marketed as a bulk drug for various preparations. The nitroimidazole antibiotic is used to treat appendicitis and pelvic inflammatory disease caused by anaerobic bacteria.